nodes	percent_of_prediction	percent_of_DWPC	metapath
Vinorelbine—ABCB1—Mitomycin—urinary bladder cancer	0.108	0.361	CbGbCtD
Vinorelbine—CYP3A4—Thiotepa—urinary bladder cancer	0.0492	0.164	CbGbCtD
Vinorelbine—ABCB1—Gemcitabine—urinary bladder cancer	0.0312	0.104	CbGbCtD
Vinorelbine—ABCB1—Cisplatin—urinary bladder cancer	0.0227	0.0755	CbGbCtD
Vinorelbine—ABCB1—Etoposide—urinary bladder cancer	0.0223	0.0741	CbGbCtD
Vinorelbine—ABCB1—Doxorubicin—urinary bladder cancer	0.0152	0.0506	CbGbCtD
Vinorelbine—ABCB1—Methotrexate—urinary bladder cancer	0.0147	0.049	CbGbCtD
Vinorelbine—CYP2D6—Doxorubicin—urinary bladder cancer	0.0143	0.0476	CbGbCtD
Vinorelbine—CYP3A4—Etoposide—urinary bladder cancer	0.0133	0.0444	CbGbCtD
Vinorelbine—CYP3A4—Doxorubicin—urinary bladder cancer	0.0091	0.0303	CbGbCtD
Vinorelbine—TUBB4A—prostate gland—urinary bladder cancer	0.00475	0.0356	CbGeAlD
Vinorelbine—TUBB2B—prostate gland—urinary bladder cancer	0.00459	0.0345	CbGeAlD
Vinorelbine—TUBB—prostate gland—urinary bladder cancer	0.00434	0.0326	CbGeAlD
Vinorelbine—TUBB2A—prostate gland—urinary bladder cancer	0.00432	0.0324	CbGeAlD
Vinorelbine—TUBB6—prostate gland—urinary bladder cancer	0.00426	0.032	CbGeAlD
Vinorelbine—CYP3A4—urine—urinary bladder cancer	0.00424	0.0318	CbGeAlD
Vinorelbine—CYP2D6—urine—urinary bladder cancer	0.00417	0.0313	CbGeAlD
Vinorelbine—TUBB2B—seminal vesicle—urinary bladder cancer	0.00388	0.0291	CbGeAlD
Vinorelbine—TUBB6—Zalcitabine—Gemcitabine—urinary bladder cancer	0.00388	0.582	CbGdCrCtD
Vinorelbine—TUBB4B—prostate gland—urinary bladder cancer	0.0037	0.0278	CbGeAlD
Vinorelbine—TUBB—seminal vesicle—urinary bladder cancer	0.00367	0.0276	CbGeAlD
Vinorelbine—TUBB2A—seminal vesicle—urinary bladder cancer	0.00365	0.0274	CbGeAlD
Vinorelbine—TUBB6—seminal vesicle—urinary bladder cancer	0.0036	0.0271	CbGeAlD
Vinorelbine—TUBB4A—renal system—urinary bladder cancer	0.00324	0.0243	CbGeAlD
Vinorelbine—TUBB4B—seminal vesicle—urinary bladder cancer	0.00313	0.0235	CbGeAlD
Vinorelbine—TUBB6—epithelium—urinary bladder cancer	0.00313	0.0235	CbGeAlD
Vinorelbine—TUBB2B—renal system—urinary bladder cancer	0.00313	0.0235	CbGeAlD
Vinorelbine—TUBB—smooth muscle tissue—urinary bladder cancer	0.00307	0.0231	CbGeAlD
Vinorelbine—TUBB2B—urethra—urinary bladder cancer	0.00307	0.0231	CbGeAlD
Vinorelbine—TUBB2A—smooth muscle tissue—urinary bladder cancer	0.00306	0.023	CbGeAlD
Vinorelbine—TUBB6—smooth muscle tissue—urinary bladder cancer	0.00302	0.0226	CbGeAlD
Vinorelbine—TUBB—urethra—urinary bladder cancer	0.00291	0.0218	CbGeAlD
Vinorelbine—TUBB6—renal system—urinary bladder cancer	0.0029	0.0218	CbGeAlD
Vinorelbine—TUBB2A—urethra—urinary bladder cancer	0.00289	0.0217	CbGeAlD
Vinorelbine—TUBB6—urethra—urinary bladder cancer	0.00285	0.0214	CbGeAlD
Vinorelbine—TUBB4B—smooth muscle tissue—urinary bladder cancer	0.00262	0.0197	CbGeAlD
Vinorelbine—TUBB4A—female reproductive system—urinary bladder cancer	0.00259	0.0195	CbGeAlD
Vinorelbine—TUBB4B—renal system—urinary bladder cancer	0.00252	0.019	CbGeAlD
Vinorelbine—TUBB2B—female reproductive system—urinary bladder cancer	0.0025	0.0188	CbGeAlD
Vinorelbine—TUBB4B—urethra—urinary bladder cancer	0.00248	0.0186	CbGeAlD
Vinorelbine—TUBB2A—female reproductive system—urinary bladder cancer	0.00236	0.0177	CbGeAlD
Vinorelbine—TUBB6—female reproductive system—urinary bladder cancer	0.00233	0.0175	CbGeAlD
Vinorelbine—TUBB2B—vagina—urinary bladder cancer	0.00227	0.017	CbGeAlD
Vinorelbine—TUBB—vagina—urinary bladder cancer	0.00214	0.0161	CbGeAlD
Vinorelbine—TUBB2A—vagina—urinary bladder cancer	0.00213	0.016	CbGeAlD
Vinorelbine—TUBB6—vagina—urinary bladder cancer	0.0021	0.0158	CbGeAlD
Vinorelbine—TUBB4B—female reproductive system—urinary bladder cancer	0.00202	0.0152	CbGeAlD
Vinorelbine—TUBB—Azacitidine—Gemcitabine—urinary bladder cancer	0.00197	0.296	CbGdCrCtD
Vinorelbine—TUBB4B—vagina—urinary bladder cancer	0.00183	0.0137	CbGeAlD
Vinorelbine—TUBB4A—lymph node—urinary bladder cancer	0.00152	0.0114	CbGeAlD
Vinorelbine—TUBB2B—lymph node—urinary bladder cancer	0.00147	0.011	CbGeAlD
Vinorelbine—TUBB—lymph node—urinary bladder cancer	0.00139	0.0104	CbGeAlD
Vinorelbine—TUBB2A—lymph node—urinary bladder cancer	0.00138	0.0104	CbGeAlD
Vinorelbine—TUBB6—lymph node—urinary bladder cancer	0.00136	0.0102	CbGeAlD
Vinorelbine—TUBB4B—lymph node—urinary bladder cancer	0.00118	0.00888	CbGeAlD
Vinorelbine—ABCB1—prostate gland—urinary bladder cancer	0.00108	0.00809	CbGeAlD
Vinorelbine—CYP3A4—renal system—urinary bladder cancer	0.00104	0.00779	CbGeAlD
Vinorelbine—CYP2D6—renal system—urinary bladder cancer	0.00102	0.00766	CbGeAlD
Vinorelbine—ABCB1—seminal vesicle—urinary bladder cancer	0.000911	0.00684	CbGeAlD
Vinorelbine—CYP3A4—female reproductive system—urinary bladder cancer	0.00083	0.00624	CbGeAlD
Vinorelbine—CYP2D6—female reproductive system—urinary bladder cancer	0.000817	0.00614	CbGeAlD
Vinorelbine—TUBB6—Azacitidine—Gemcitabine—urinary bladder cancer	0.000816	0.122	CbGdCrCtD
Vinorelbine—ABCB1—epithelium—urinary bladder cancer	0.000791	0.00594	CbGeAlD
Vinorelbine—ABCB1—renal system—urinary bladder cancer	0.000734	0.00551	CbGeAlD
Vinorelbine—ABCB1—urethra—urinary bladder cancer	0.000721	0.00541	CbGeAlD
Vinorelbine—ABCB1—female reproductive system—urinary bladder cancer	0.000588	0.00441	CbGeAlD
Vinorelbine—ABCB1—vagina—urinary bladder cancer	0.000532	0.00399	CbGeAlD
Vinorelbine—ABCB1—lymph node—urinary bladder cancer	0.000344	0.00258	CbGeAlD
Vinorelbine—Pneumonia—Methotrexate—urinary bladder cancer	0.000237	0.000504	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Cisplatin—urinary bladder cancer	0.000237	0.000503	CcSEcCtD
Vinorelbine—Infestation NOS—Methotrexate—urinary bladder cancer	0.000236	0.000501	CcSEcCtD
Vinorelbine—Infestation—Methotrexate—urinary bladder cancer	0.000236	0.000501	CcSEcCtD
Vinorelbine—Pancytopenia—Epirubicin—urinary bladder cancer	0.000235	0.000499	CcSEcCtD
Vinorelbine—Hypotension—Etoposide—urinary bladder cancer	0.000235	0.000498	CcSEcCtD
Vinorelbine—Pain—Cisplatin—urinary bladder cancer	0.000235	0.000498	CcSEcCtD
Vinorelbine—Muscular weakness—Doxorubicin—urinary bladder cancer	0.000234	0.000496	CcSEcCtD
Vinorelbine—Body temperature increased—Gemcitabine—urinary bladder cancer	0.000233	0.000494	CcSEcCtD
Vinorelbine—Neutropenia—Epirubicin—urinary bladder cancer	0.000232	0.000492	CcSEcCtD
Vinorelbine—Dizziness—Thiotepa—urinary bladder cancer	0.000231	0.000491	CcSEcCtD
Vinorelbine—Stomatitis—Methotrexate—urinary bladder cancer	0.00023	0.000488	CcSEcCtD
Vinorelbine—Urticaria—Fluorouracil—urinary bladder cancer	0.00023	0.000488	CcSEcCtD
Vinorelbine—Dysphagia—Doxorubicin—urinary bladder cancer	0.000229	0.000486	CcSEcCtD
Vinorelbine—Body temperature increased—Fluorouracil—urinary bladder cancer	0.000229	0.000485	CcSEcCtD
Vinorelbine—Feeling abnormal—Cisplatin—urinary bladder cancer	0.000226	0.00048	CcSEcCtD
Vinorelbine—Paraesthesia—Etoposide—urinary bladder cancer	0.000226	0.000479	CcSEcCtD
Vinorelbine—Pancreatitis—Doxorubicin—urinary bladder cancer	0.000225	0.000477	CcSEcCtD
Vinorelbine—Weight decreased—Epirubicin—urinary bladder cancer	0.000224	0.000476	CcSEcCtD
Vinorelbine—Dyspnoea—Etoposide—urinary bladder cancer	0.000224	0.000475	CcSEcCtD
Vinorelbine—Angina pectoris—Doxorubicin—urinary bladder cancer	0.000223	0.000474	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Methotrexate—urinary bladder cancer	0.000223	0.000474	CcSEcCtD
Vinorelbine—Vomiting—Thiotepa—urinary bladder cancer	0.000222	0.000472	CcSEcCtD
Vinorelbine—Pneumonia—Epirubicin—urinary bladder cancer	0.000222	0.000471	CcSEcCtD
Vinorelbine—Infestation NOS—Epirubicin—urinary bladder cancer	0.000221	0.000469	CcSEcCtD
Vinorelbine—Infestation—Epirubicin—urinary bladder cancer	0.000221	0.000469	CcSEcCtD
Vinorelbine—Rash—Thiotepa—urinary bladder cancer	0.000221	0.000468	CcSEcCtD
Vinorelbine—Dermatitis—Thiotepa—urinary bladder cancer	0.00022	0.000468	CcSEcCtD
Vinorelbine—Agranulocytosis—Methotrexate—urinary bladder cancer	0.00022	0.000467	CcSEcCtD
Vinorelbine—Headache—Thiotepa—urinary bladder cancer	0.000219	0.000465	CcSEcCtD
Vinorelbine—Decreased appetite—Etoposide—urinary bladder cancer	0.000218	0.000464	CcSEcCtD
Vinorelbine—Pancytopenia—Doxorubicin—urinary bladder cancer	0.000218	0.000462	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Etoposide—urinary bladder cancer	0.000217	0.00046	CcSEcCtD
Vinorelbine—Body temperature increased—Cisplatin—urinary bladder cancer	0.000217	0.00046	CcSEcCtD
Vinorelbine—Fatigue—Etoposide—urinary bladder cancer	0.000217	0.00046	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Epirubicin—urinary bladder cancer	0.000216	0.000459	CcSEcCtD
Vinorelbine—Stomatitis—Epirubicin—urinary bladder cancer	0.000215	0.000457	CcSEcCtD
Vinorelbine—Constipation—Etoposide—urinary bladder cancer	0.000215	0.000456	CcSEcCtD
Vinorelbine—Pain—Etoposide—urinary bladder cancer	0.000215	0.000456	CcSEcCtD
Vinorelbine—Neutropenia—Doxorubicin—urinary bladder cancer	0.000214	0.000455	CcSEcCtD
Vinorelbine—Hypersensitivity—Fluorouracil—urinary bladder cancer	0.000213	0.000452	CcSEcCtD
Vinorelbine—Asthenia—Gemcitabine—urinary bladder cancer	0.000211	0.000448	CcSEcCtD
Vinorelbine—Hepatobiliary disease—Epirubicin—urinary bladder cancer	0.000209	0.000443	CcSEcCtD
Vinorelbine—Pruritus—Gemcitabine—urinary bladder cancer	0.000208	0.000442	CcSEcCtD
Vinorelbine—Nausea—Thiotepa—urinary bladder cancer	0.000208	0.000441	CcSEcCtD
Vinorelbine—Weight decreased—Doxorubicin—urinary bladder cancer	0.000207	0.00044	CcSEcCtD
Vinorelbine—Feeling abnormal—Etoposide—urinary bladder cancer	0.000207	0.000439	CcSEcCtD
Vinorelbine—Agranulocytosis—Epirubicin—urinary bladder cancer	0.000206	0.000437	CcSEcCtD
Vinorelbine—Pneumonia—Doxorubicin—urinary bladder cancer	0.000206	0.000436	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Etoposide—urinary bladder cancer	0.000205	0.000436	CcSEcCtD
Vinorelbine—Pruritus—Fluorouracil—urinary bladder cancer	0.000205	0.000434	CcSEcCtD
Vinorelbine—Infestation NOS—Doxorubicin—urinary bladder cancer	0.000204	0.000434	CcSEcCtD
Vinorelbine—Infestation—Doxorubicin—urinary bladder cancer	0.000204	0.000434	CcSEcCtD
Vinorelbine—Hypersensitivity—Cisplatin—urinary bladder cancer	0.000202	0.000429	CcSEcCtD
Vinorelbine—Diarrhoea—Gemcitabine—urinary bladder cancer	0.000201	0.000427	CcSEcCtD
Vinorelbine—Neuropathy peripheral—Doxorubicin—urinary bladder cancer	0.0002	0.000425	CcSEcCtD
Vinorelbine—Urticaria—Etoposide—urinary bladder cancer	0.0002	0.000424	CcSEcCtD
Vinorelbine—Stomatitis—Doxorubicin—urinary bladder cancer	0.000199	0.000423	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RRM2—urinary bladder cancer	0.000199	0.00224	CbGpPWpGaD
Vinorelbine—Abdominal pain—Etoposide—urinary bladder cancer	0.000199	0.000422	CcSEcCtD
Vinorelbine—Body temperature increased—Etoposide—urinary bladder cancer	0.000199	0.000422	CcSEcCtD
Vinorelbine—Diarrhoea—Fluorouracil—urinary bladder cancer	0.000198	0.00042	CcSEcCtD
Vinorelbine—Hypoaesthesia—Epirubicin—urinary bladder cancer	0.000197	0.000419	CcSEcCtD
Vinorelbine—Asthenia—Cisplatin—urinary bladder cancer	0.000197	0.000418	CcSEcCtD
Vinorelbine—Cardiac disorder—Methotrexate—urinary bladder cancer	0.000197	0.000417	CcSEcCtD
Vinorelbine—Connective tissue disorder—Epirubicin—urinary bladder cancer	0.000195	0.000413	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—RRM2—urinary bladder cancer	0.000194	0.00219	CbGpPWpGaD
Vinorelbine—Hepatobiliary disease—Doxorubicin—urinary bladder cancer	0.000193	0.00041	CcSEcCtD
Vinorelbine—Angiopathy—Methotrexate—urinary bladder cancer	0.000192	0.000408	CcSEcCtD
Vinorelbine—Immune system disorder—Methotrexate—urinary bladder cancer	0.000191	0.000406	CcSEcCtD
Vinorelbine—Dizziness—Fluorouracil—urinary bladder cancer	0.000191	0.000406	CcSEcCtD
Vinorelbine—Mediastinal disorder—Methotrexate—urinary bladder cancer	0.000191	0.000405	CcSEcCtD
Vinorelbine—Agranulocytosis—Doxorubicin—urinary bladder cancer	0.000191	0.000405	CcSEcCtD
Vinorelbine—Diarrhoea—Cisplatin—urinary bladder cancer	0.000188	0.000398	CcSEcCtD
Vinorelbine—Alopecia—Methotrexate—urinary bladder cancer	0.000187	0.000397	CcSEcCtD
Vinorelbine—Vomiting—Gemcitabine—urinary bladder cancer	0.000187	0.000397	CcSEcCtD
Vinorelbine—CYP3A4—Biological oxidations—GSTZ1—urinary bladder cancer	0.000187	0.0021	CbGpPWpGaD
Vinorelbine—Rash—Gemcitabine—urinary bladder cancer	0.000186	0.000394	CcSEcCtD
Vinorelbine—Dermatitis—Gemcitabine—urinary bladder cancer	0.000185	0.000393	CcSEcCtD
Vinorelbine—Hypersensitivity—Etoposide—urinary bladder cancer	0.000185	0.000393	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000185	0.00208	CbGpPWpGaD
Vinorelbine—Erythema—Methotrexate—urinary bladder cancer	0.000184	0.000391	CcSEcCtD
Vinorelbine—Malnutrition—Methotrexate—urinary bladder cancer	0.000184	0.000391	CcSEcCtD
Vinorelbine—Headache—Gemcitabine—urinary bladder cancer	0.000184	0.000391	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTZ1—urinary bladder cancer	0.000184	0.00207	CbGpPWpGaD
Vinorelbine—Cardiac disorder—Epirubicin—urinary bladder cancer	0.000184	0.00039	CcSEcCtD
Vinorelbine—Flushing—Epirubicin—urinary bladder cancer	0.000184	0.00039	CcSEcCtD
Vinorelbine—Vomiting—Fluorouracil—urinary bladder cancer	0.000184	0.00039	CcSEcCtD
Vinorelbine—TUBB4A—G2/M Transition—EP300—urinary bladder cancer	0.000183	0.00207	CbGpPWpGaD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000183	0.00206	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000183	0.00206	CbGpPWpGaD
Vinorelbine—Hypoaesthesia—Doxorubicin—urinary bladder cancer	0.000183	0.000387	CcSEcCtD
Vinorelbine—Rash—Fluorouracil—urinary bladder cancer	0.000182	0.000387	CcSEcCtD
Vinorelbine—Dermatitis—Fluorouracil—urinary bladder cancer	0.000182	0.000387	CcSEcCtD
Vinorelbine—TUBB2B—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000182	0.00205	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000182	0.00205	CbGpPWpGaD
Vinorelbine—Headache—Fluorouracil—urinary bladder cancer	0.000181	0.000385	CcSEcCtD
Vinorelbine—TUBB4A—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000181	0.00204	CbGpPWpGaD
Vinorelbine—Asthenia—Etoposide—urinary bladder cancer	0.00018	0.000383	CcSEcCtD
Vinorelbine—Connective tissue disorder—Doxorubicin—urinary bladder cancer	0.00018	0.000383	CcSEcCtD
Vinorelbine—Angiopathy—Epirubicin—urinary bladder cancer	0.00018	0.000382	CcSEcCtD
Vinorelbine—Immune system disorder—Epirubicin—urinary bladder cancer	0.000179	0.00038	CcSEcCtD
Vinorelbine—Mediastinal disorder—Epirubicin—urinary bladder cancer	0.000179	0.000379	CcSEcCtD
Vinorelbine—Back pain—Methotrexate—urinary bladder cancer	0.000178	0.000379	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—RRM2—urinary bladder cancer	0.000178	0.002	CbGpPWpGaD
Vinorelbine—Pruritus—Etoposide—urinary bladder cancer	0.000178	0.000377	CcSEcCtD
Vinorelbine—Arrhythmia—Epirubicin—urinary bladder cancer	0.000177	0.000376	CcSEcCtD
Vinorelbine—CYP3A4—Biological oxidations—GSTO2—urinary bladder cancer	0.000177	0.00199	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—NAT1—urinary bladder cancer	0.000177	0.00199	CbGpPWpGaD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000177	0.00199	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000175	0.00198	CbGpPWpGaD
Vinorelbine—Alopecia—Epirubicin—urinary bladder cancer	0.000175	0.000372	CcSEcCtD
Vinorelbine—Nausea—Gemcitabine—urinary bladder cancer	0.000175	0.000371	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTO2—urinary bladder cancer	0.000174	0.00197	CbGpPWpGaD
Vinorelbine—Vomiting—Cisplatin—urinary bladder cancer	0.000174	0.00037	CcSEcCtD
Vinorelbine—Rash—Cisplatin—urinary bladder cancer	0.000173	0.000367	CcSEcCtD
Vinorelbine—Dermatitis—Cisplatin—urinary bladder cancer	0.000173	0.000367	CcSEcCtD
Vinorelbine—Malnutrition—Epirubicin—urinary bladder cancer	0.000173	0.000366	CcSEcCtD
Vinorelbine—Erythema—Epirubicin—urinary bladder cancer	0.000173	0.000366	CcSEcCtD
Vinorelbine—Diarrhoea—Etoposide—urinary bladder cancer	0.000172	0.000365	CcSEcCtD
Vinorelbine—Nausea—Fluorouracil—urinary bladder cancer	0.000172	0.000365	CcSEcCtD
Vinorelbine—Ill-defined disorder—Methotrexate—urinary bladder cancer	0.000171	0.000363	CcSEcCtD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000171	0.00193	CbGpPWpGaD
Vinorelbine—Anaemia—Methotrexate—urinary bladder cancer	0.00017	0.000362	CcSEcCtD
Vinorelbine—Cardiac disorder—Doxorubicin—urinary bladder cancer	0.00017	0.000361	CcSEcCtD
Vinorelbine—Flushing—Doxorubicin—urinary bladder cancer	0.00017	0.000361	CcSEcCtD
Vinorelbine—TUBB2A—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.00017	0.00192	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—SMC1A—urinary bladder cancer	0.000169	0.00191	CbGpPWpGaD
Vinorelbine—TUBB4B—G2/M Transition—EP300—urinary bladder cancer	0.000168	0.00189	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000167	0.00188	CbGpPWpGaD
Vinorelbine—Back pain—Epirubicin—urinary bladder cancer	0.000167	0.000354	CcSEcCtD
Vinorelbine—Angiopathy—Doxorubicin—urinary bladder cancer	0.000166	0.000353	CcSEcCtD
Vinorelbine—Malaise—Methotrexate—urinary bladder cancer	0.000166	0.000353	CcSEcCtD
Vinorelbine—Dizziness—Etoposide—urinary bladder cancer	0.000166	0.000353	CcSEcCtD
Vinorelbine—TUBB1—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000166	0.00187	CbGpPWpGaD
Vinorelbine—Immune system disorder—Doxorubicin—urinary bladder cancer	0.000166	0.000352	CcSEcCtD
Vinorelbine—Vertigo—Methotrexate—urinary bladder cancer	0.000166	0.000352	CcSEcCtD
Vinorelbine—TUBB4B—Mitotic G2-G2/M phases—EP300—urinary bladder cancer	0.000165	0.00186	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—SMC1A—urinary bladder cancer	0.000165	0.00186	CbGpPWpGaD
Vinorelbine—Mediastinal disorder—Doxorubicin—urinary bladder cancer	0.000165	0.000351	CcSEcCtD
Vinorelbine—Leukopenia—Methotrexate—urinary bladder cancer	0.000165	0.00035	CcSEcCtD
Vinorelbine—Arrhythmia—Doxorubicin—urinary bladder cancer	0.000164	0.000348	CcSEcCtD
Vinorelbine—Nausea—Cisplatin—urinary bladder cancer	0.000163	0.000346	CcSEcCtD
Vinorelbine—Alopecia—Doxorubicin—urinary bladder cancer	0.000162	0.000344	CcSEcCtD
Vinorelbine—CYP3A4—Biological oxidations—UGT2B7—urinary bladder cancer	0.000162	0.00182	CbGpPWpGaD
Vinorelbine—Cough—Methotrexate—urinary bladder cancer	0.000161	0.000342	CcSEcCtD
Vinorelbine—Ill-defined disorder—Epirubicin—urinary bladder cancer	0.00016	0.00034	CcSEcCtD
Vinorelbine—Vomiting—Etoposide—urinary bladder cancer	0.00016	0.000339	CcSEcCtD
Vinorelbine—Malnutrition—Doxorubicin—urinary bladder cancer	0.00016	0.000339	CcSEcCtD
Vinorelbine—Erythema—Doxorubicin—urinary bladder cancer	0.00016	0.000339	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—UGT2B7—urinary bladder cancer	0.00016	0.0018	CbGpPWpGaD
Vinorelbine—Anaemia—Epirubicin—urinary bladder cancer	0.00016	0.000339	CcSEcCtD
Vinorelbine—Rash—Etoposide—urinary bladder cancer	0.000158	0.000336	CcSEcCtD
Vinorelbine—Dermatitis—Etoposide—urinary bladder cancer	0.000158	0.000336	CcSEcCtD
Vinorelbine—Headache—Etoposide—urinary bladder cancer	0.000157	0.000334	CcSEcCtD
Vinorelbine—Myalgia—Methotrexate—urinary bladder cancer	0.000157	0.000333	CcSEcCtD
Vinorelbine—Chest pain—Methotrexate—urinary bladder cancer	0.000157	0.000333	CcSEcCtD
Vinorelbine—Arthralgia—Methotrexate—urinary bladder cancer	0.000157	0.000333	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—urinary bladder cancer	0.000156	0.000331	CcSEcCtD
Vinorelbine—Malaise—Epirubicin—urinary bladder cancer	0.000156	0.00033	CcSEcCtD
Vinorelbine—Discomfort—Methotrexate—urinary bladder cancer	0.000155	0.000329	CcSEcCtD
Vinorelbine—Vertigo—Epirubicin—urinary bladder cancer	0.000155	0.000329	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000155	0.00174	CbGpPWpGaD
Vinorelbine—Leukopenia—Epirubicin—urinary bladder cancer	0.000154	0.000328	CcSEcCtD
Vinorelbine—Back pain—Doxorubicin—urinary bladder cancer	0.000154	0.000328	CcSEcCtD
Vinorelbine—Palpitations—Epirubicin—urinary bladder cancer	0.000153	0.000324	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000152	0.00171	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—LIG1—urinary bladder cancer	0.000152	0.00171	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—SMC1A—urinary bladder cancer	0.000151	0.0017	CbGpPWpGaD
Vinorelbine—Cough—Epirubicin—urinary bladder cancer	0.000151	0.00032	CcSEcCtD
Vinorelbine—Anaphylactic shock—Methotrexate—urinary bladder cancer	0.000151	0.000319	CcSEcCtD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.00015	0.00169	CbGpPWpGaD
Vinorelbine—Infection—Methotrexate—urinary bladder cancer	0.00015	0.000317	CcSEcCtD
Vinorelbine—Nausea—Etoposide—urinary bladder cancer	0.000149	0.000317	CcSEcCtD
Vinorelbine—TUBB4A—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000149	0.00168	CbGpPWpGaD
Vinorelbine—Hypertension—Epirubicin—urinary bladder cancer	0.000149	0.000316	CcSEcCtD
Vinorelbine—CYP2D6—Biological oxidations—NAT2—urinary bladder cancer	0.000148	0.00167	CbGpPWpGaD
Vinorelbine—Ill-defined disorder—Doxorubicin—urinary bladder cancer	0.000148	0.000314	CcSEcCtD
Vinorelbine—Nervous system disorder—Methotrexate—urinary bladder cancer	0.000148	0.000313	CcSEcCtD
Vinorelbine—Anaemia—Doxorubicin—urinary bladder cancer	0.000148	0.000313	CcSEcCtD
Vinorelbine—Thrombocytopenia—Methotrexate—urinary bladder cancer	0.000147	0.000313	CcSEcCtD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—TERT—urinary bladder cancer	0.000147	0.00166	CbGpPWpGaD
Vinorelbine—Arthralgia—Epirubicin—urinary bladder cancer	0.000147	0.000312	CcSEcCtD
Vinorelbine—Chest pain—Epirubicin—urinary bladder cancer	0.000147	0.000312	CcSEcCtD
Vinorelbine—Myalgia—Epirubicin—urinary bladder cancer	0.000147	0.000312	CcSEcCtD
Vinorelbine—Skin disorder—Methotrexate—urinary bladder cancer	0.000146	0.00031	CcSEcCtD
Vinorelbine—CYP2D6—Metapathway biotransformation—NAT2—urinary bladder cancer	0.000146	0.00165	CbGpPWpGaD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—urinary bladder cancer	0.000146	0.00031	CcSEcCtD
Vinorelbine—CYP3A4—Biological oxidations—CYP4B1—urinary bladder cancer	0.000146	0.00164	CbGpPWpGaD
Vinorelbine—Discomfort—Epirubicin—urinary bladder cancer	0.000145	0.000308	CcSEcCtD
Vinorelbine—Malaise—Doxorubicin—urinary bladder cancer	0.000144	0.000306	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—CYP4B1—urinary bladder cancer	0.000144	0.00162	CbGpPWpGaD
Vinorelbine—Vertigo—Doxorubicin—urinary bladder cancer	0.000143	0.000304	CcSEcCtD
Vinorelbine—Anorexia—Methotrexate—urinary bladder cancer	0.000143	0.000304	CcSEcCtD
Vinorelbine—Leukopenia—Doxorubicin—urinary bladder cancer	0.000143	0.000303	CcSEcCtD
Vinorelbine—Palpitations—Doxorubicin—urinary bladder cancer	0.000141	0.000299	CcSEcCtD
Vinorelbine—Anaphylactic shock—Epirubicin—urinary bladder cancer	0.000141	0.000299	CcSEcCtD
Vinorelbine—Hypotension—Methotrexate—urinary bladder cancer	0.000141	0.000298	CcSEcCtD
Vinorelbine—Infection—Epirubicin—urinary bladder cancer	0.00014	0.000297	CcSEcCtD
Vinorelbine—Cough—Doxorubicin—urinary bladder cancer	0.000139	0.000296	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CCNE1—urinary bladder cancer	0.000138	0.00156	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Epirubicin—urinary bladder cancer	0.000138	0.000293	CcSEcCtD
Vinorelbine—Thrombocytopenia—Epirubicin—urinary bladder cancer	0.000138	0.000293	CcSEcCtD
Vinorelbine—Hypertension—Doxorubicin—urinary bladder cancer	0.000138	0.000293	CcSEcCtD
Vinorelbine—Tachycardia—Epirubicin—urinary bladder cancer	0.000137	0.000292	CcSEcCtD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	0.000137	0.00155	CbGpPWpGaD
Vinorelbine—Musculoskeletal discomfort—Methotrexate—urinary bladder cancer	0.000137	0.000291	CcSEcCtD
Vinorelbine—Skin disorder—Epirubicin—urinary bladder cancer	0.000137	0.00029	CcSEcCtD
Vinorelbine—TUBB4B—Metabolism of proteins—IGFBP3—urinary bladder cancer	0.000136	0.00154	CbGpPWpGaD
Vinorelbine—Arthralgia—Doxorubicin—urinary bladder cancer	0.000136	0.000289	CcSEcCtD
Vinorelbine—Myalgia—Doxorubicin—urinary bladder cancer	0.000136	0.000289	CcSEcCtD
Vinorelbine—Chest pain—Doxorubicin—urinary bladder cancer	0.000136	0.000289	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—TYMS—urinary bladder cancer	0.000136	0.00153	CbGpPWpGaD
Vinorelbine—Paraesthesia—Methotrexate—urinary bladder cancer	0.000135	0.000287	CcSEcCtD
Vinorelbine—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—urinary bladder cancer	0.000135	0.000287	CcSEcCtD
Vinorelbine—Discomfort—Doxorubicin—urinary bladder cancer	0.000134	0.000285	CcSEcCtD
Vinorelbine—Anorexia—Epirubicin—urinary bladder cancer	0.000134	0.000285	CcSEcCtD
Vinorelbine—Dyspnoea—Methotrexate—urinary bladder cancer	0.000134	0.000285	CcSEcCtD
Vinorelbine—Hypotension—Epirubicin—urinary bladder cancer	0.000132	0.000279	CcSEcCtD
Vinorelbine—Decreased appetite—Methotrexate—urinary bladder cancer	0.000131	0.000278	CcSEcCtD
Vinorelbine—Anaphylactic shock—Doxorubicin—urinary bladder cancer	0.00013	0.000277	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Methotrexate—urinary bladder cancer	0.00013	0.000276	CcSEcCtD
Vinorelbine—ABCB1—Allograft Rejection—FAS—urinary bladder cancer	0.00013	0.00146	CbGpPWpGaD
Vinorelbine—Fatigue—Methotrexate—urinary bladder cancer	0.00013	0.000275	CcSEcCtD
Vinorelbine—Infection—Doxorubicin—urinary bladder cancer	0.000129	0.000275	CcSEcCtD
Vinorelbine—Pain—Methotrexate—urinary bladder cancer	0.000129	0.000273	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Epirubicin—urinary bladder cancer	0.000128	0.000272	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000128	0.00144	CbGpPWpGaD
Vinorelbine—Nervous system disorder—Doxorubicin—urinary bladder cancer	0.000128	0.000271	CcSEcCtD
Vinorelbine—Thrombocytopenia—Doxorubicin—urinary bladder cancer	0.000128	0.000271	CcSEcCtD
Vinorelbine—Tachycardia—Doxorubicin—urinary bladder cancer	0.000127	0.00027	CcSEcCtD
Vinorelbine—Skin disorder—Doxorubicin—urinary bladder cancer	0.000127	0.000269	CcSEcCtD
Vinorelbine—Paraesthesia—Epirubicin—urinary bladder cancer	0.000126	0.000268	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000126	0.00142	CbGpPWpGaD
Vinorelbine—Dyspnoea—Epirubicin—urinary bladder cancer	0.000126	0.000266	CcSEcCtD
Vinorelbine—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—PPARG—urinary bladder cancer	0.000125	0.00141	CbGpPWpGaD
Vinorelbine—Anorexia—Doxorubicin—urinary bladder cancer	0.000124	0.000264	CcSEcCtD
Vinorelbine—Feeling abnormal—Methotrexate—urinary bladder cancer	0.000124	0.000263	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Methotrexate—urinary bladder cancer	0.000123	0.000261	CcSEcCtD
Vinorelbine—Decreased appetite—Epirubicin—urinary bladder cancer	0.000122	0.00026	CcSEcCtD
Vinorelbine—Hypotension—Doxorubicin—urinary bladder cancer	0.000122	0.000258	CcSEcCtD
Vinorelbine—Gastrointestinal disorder—Epirubicin—urinary bladder cancer	0.000122	0.000258	CcSEcCtD
Vinorelbine—Fatigue—Epirubicin—urinary bladder cancer	0.000121	0.000258	CcSEcCtD
Vinorelbine—Pain—Epirubicin—urinary bladder cancer	0.00012	0.000256	CcSEcCtD
Vinorelbine—Constipation—Epirubicin—urinary bladder cancer	0.00012	0.000256	CcSEcCtD
Vinorelbine—Urticaria—Methotrexate—urinary bladder cancer	0.00012	0.000254	CcSEcCtD
Vinorelbine—Abdominal pain—Methotrexate—urinary bladder cancer	0.000119	0.000252	CcSEcCtD
Vinorelbine—Body temperature increased—Methotrexate—urinary bladder cancer	0.000119	0.000252	CcSEcCtD
Vinorelbine—Musculoskeletal discomfort—Doxorubicin—urinary bladder cancer	0.000119	0.000252	CcSEcCtD
Vinorelbine—CYP2D6—Biological oxidations—HPGDS—urinary bladder cancer	0.000118	0.00134	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	0.000118	0.00134	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TERT—urinary bladder cancer	0.000118	0.00133	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCNE1—urinary bladder cancer	0.000117	0.00132	CbGpPWpGaD
Vinorelbine—Paraesthesia—Doxorubicin—urinary bladder cancer	0.000117	0.000248	CcSEcCtD
Vinorelbine—Dyspnoea—Doxorubicin—urinary bladder cancer	0.000116	0.000247	CcSEcCtD
Vinorelbine—Feeling abnormal—Epirubicin—urinary bladder cancer	0.000116	0.000246	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—HPGDS—urinary bladder cancer	0.000116	0.0013	CbGpPWpGaD
Vinorelbine—Gastrointestinal pain—Epirubicin—urinary bladder cancer	0.000115	0.000244	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—TYMS—urinary bladder cancer	0.000115	0.0013	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—CREBBP—urinary bladder cancer	0.000115	0.0013	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTT1—urinary bladder cancer	0.000115	0.0013	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IGFBP3—urinary bladder cancer	0.000115	0.0013	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCNE1—urinary bladder cancer	0.000115	0.00129	CbGpPWpGaD
Vinorelbine—Decreased appetite—Doxorubicin—urinary bladder cancer	0.000113	0.00024	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—TYMS—urinary bladder cancer	0.000113	0.00127	CbGpPWpGaD
Vinorelbine—Gastrointestinal disorder—Doxorubicin—urinary bladder cancer	0.000113	0.000239	CcSEcCtD
Vinorelbine—Fatigue—Doxorubicin—urinary bladder cancer	0.000112	0.000238	CcSEcCtD
Vinorelbine—Urticaria—Epirubicin—urinary bladder cancer	0.000112	0.000237	CcSEcCtD
Vinorelbine—Constipation—Doxorubicin—urinary bladder cancer	0.000111	0.000237	CcSEcCtD
Vinorelbine—Pain—Doxorubicin—urinary bladder cancer	0.000111	0.000237	CcSEcCtD
Vinorelbine—Body temperature increased—Epirubicin—urinary bladder cancer	0.000111	0.000236	CcSEcCtD
Vinorelbine—Abdominal pain—Epirubicin—urinary bladder cancer	0.000111	0.000236	CcSEcCtD
Vinorelbine—Hypersensitivity—Methotrexate—urinary bladder cancer	0.000111	0.000235	CcSEcCtD
Vinorelbine—Asthenia—Methotrexate—urinary bladder cancer	0.000108	0.000229	CcSEcCtD
Vinorelbine—Feeling abnormal—Doxorubicin—urinary bladder cancer	0.000107	0.000228	CcSEcCtD
Vinorelbine—Gastrointestinal pain—Doxorubicin—urinary bladder cancer	0.000107	0.000226	CcSEcCtD
Vinorelbine—Pruritus—Methotrexate—urinary bladder cancer	0.000106	0.000226	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—ATM—urinary bladder cancer	0.000106	0.0012	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDK4—urinary bladder cancer	0.000106	0.00119	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCNE1—urinary bladder cancer	0.000105	0.00118	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—SLC14A2—urinary bladder cancer	0.000105	0.00118	CbGpPWpGaD
Vinorelbine—Hypersensitivity—Epirubicin—urinary bladder cancer	0.000104	0.00022	CcSEcCtD
Vinorelbine—Urticaria—Doxorubicin—urinary bladder cancer	0.000104	0.00022	CcSEcCtD
Vinorelbine—Abdominal pain—Doxorubicin—urinary bladder cancer	0.000103	0.000219	CcSEcCtD
Vinorelbine—Body temperature increased—Doxorubicin—urinary bladder cancer	0.000103	0.000219	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle, Mitotic—RB1—urinary bladder cancer	0.000103	0.00116	CbGpPWpGaD
Vinorelbine—Diarrhoea—Methotrexate—urinary bladder cancer	0.000103	0.000219	CcSEcCtD
Vinorelbine—TUBB4B—Cell Cycle—TYMS—urinary bladder cancer	0.000103	0.00116	CbGpPWpGaD
Vinorelbine—Asthenia—Epirubicin—urinary bladder cancer	0.000101	0.000214	CcSEcCtD
Vinorelbine—Pruritus—Epirubicin—urinary bladder cancer	9.97e-05	0.000211	CcSEcCtD
Vinorelbine—Dizziness—Methotrexate—urinary bladder cancer	9.95e-05	0.000211	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	9.82e-05	0.00111	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TERT—urinary bladder cancer	9.81e-05	0.00111	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—NAT2—urinary bladder cancer	9.69e-05	0.00109	CbGpPWpGaD
Vinorelbine—Diarrhoea—Epirubicin—urinary bladder cancer	9.64e-05	0.000205	CcSEcCtD
Vinorelbine—Hypersensitivity—Doxorubicin—urinary bladder cancer	9.6e-05	0.000204	CcSEcCtD
Vinorelbine—Vomiting—Methotrexate—urinary bladder cancer	9.57e-05	0.000203	CcSEcCtD
Vinorelbine—CYP3A4—Metapathway biotransformation—NAT2—urinary bladder cancer	9.56e-05	0.00108	CbGpPWpGaD
Vinorelbine—Rash—Methotrexate—urinary bladder cancer	9.49e-05	0.000201	CcSEcCtD
Vinorelbine—Dermatitis—Methotrexate—urinary bladder cancer	9.48e-05	0.000201	CcSEcCtD
Vinorelbine—Headache—Methotrexate—urinary bladder cancer	9.43e-05	0.0002	CcSEcCtD
Vinorelbine—Asthenia—Doxorubicin—urinary bladder cancer	9.35e-05	0.000198	CcSEcCtD
Vinorelbine—Dizziness—Epirubicin—urinary bladder cancer	9.31e-05	0.000198	CcSEcCtD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR2—urinary bladder cancer	9.25e-05	0.00104	CbGpPWpGaD
Vinorelbine—Pruritus—Doxorubicin—urinary bladder cancer	9.22e-05	0.000196	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—RB1—urinary bladder cancer	9.21e-05	0.00104	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	9.05e-05	0.00102	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDK4—urinary bladder cancer	8.98e-05	0.00101	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TERT—urinary bladder cancer	8.97e-05	0.00101	CbGpPWpGaD
Vinorelbine—Vomiting—Epirubicin—urinary bladder cancer	8.96e-05	0.00019	CcSEcCtD
Vinorelbine—Nausea—Methotrexate—urinary bladder cancer	8.94e-05	0.00019	CcSEcCtD
Vinorelbine—Diarrhoea—Doxorubicin—urinary bladder cancer	8.92e-05	0.000189	CcSEcCtD
Vinorelbine—Rash—Epirubicin—urinary bladder cancer	8.88e-05	0.000188	CcSEcCtD
Vinorelbine—Dermatitis—Epirubicin—urinary bladder cancer	8.87e-05	0.000188	CcSEcCtD
Vinorelbine—Headache—Epirubicin—urinary bladder cancer	8.82e-05	0.000187	CcSEcCtD
Vinorelbine—TUBB4A—Cell Cycle—ATM—urinary bladder cancer	8.81e-05	0.000993	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDK4—urinary bladder cancer	8.78e-05	0.000989	CbGpPWpGaD
Vinorelbine—ABCB1—Imatinib Resistance in Chronic Myeloid Leukemia—MYC—urinary bladder cancer	8.67e-05	0.000977	CbGpPWpGaD
Vinorelbine—Dizziness—Doxorubicin—urinary bladder cancer	8.62e-05	0.000183	CcSEcCtD
Vinorelbine—TUBB2B—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.56e-05	0.000964	CbGpPWpGaD
Vinorelbine—TUBB6—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.56e-05	0.000964	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—RB1—urinary bladder cancer	8.53e-05	0.000962	CbGpPWpGaD
Vinorelbine—Nausea—Epirubicin—urinary bladder cancer	8.37e-05	0.000178	CcSEcCtD
Vinorelbine—Vomiting—Doxorubicin—urinary bladder cancer	8.29e-05	0.000176	CcSEcCtD
Vinorelbine—TUBB3—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8.26e-05	0.000931	CbGpPWpGaD
Vinorelbine—Rash—Doxorubicin—urinary bladder cancer	8.22e-05	0.000174	CcSEcCtD
Vinorelbine—Dermatitis—Doxorubicin—urinary bladder cancer	8.21e-05	0.000174	CcSEcCtD
Vinorelbine—Headache—Doxorubicin—urinary bladder cancer	8.16e-05	0.000173	CcSEcCtD
Vinorelbine—TUBB—Cell Cycle—CDKN2A—urinary bladder cancer	8.1e-05	0.000912	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—ATM—urinary bladder cancer	8.06e-05	0.000909	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDK4—urinary bladder cancer	8.03e-05	0.000905	CbGpPWpGaD
Vinorelbine—TUBB2A—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	8e-05	0.000902	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTP1—urinary bladder cancer	7.97e-05	0.000898	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—CXCL8—urinary bladder cancer	7.92e-05	0.000892	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTP1—urinary bladder cancer	7.86e-05	0.000886	CbGpPWpGaD
Vinorelbine—ABCB1—HIF-1-alpha transcription factor network—EP300—urinary bladder cancer	7.84e-05	0.000883	CbGpPWpGaD
Vinorelbine—TUBB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.83e-05	0.000882	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—RB1—urinary bladder cancer	7.81e-05	0.00088	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—HPGDS—urinary bladder cancer	7.75e-05	0.000873	CbGpPWpGaD
Vinorelbine—Nausea—Doxorubicin—urinary bladder cancer	7.74e-05	0.000164	CcSEcCtD
Vinorelbine—TUBB6—Metabolism of proteins—IGF1—urinary bladder cancer	7.68e-05	0.000865	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—IGF1—urinary bladder cancer	7.68e-05	0.000865	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	7.65e-05	0.000862	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—RB1—urinary bladder cancer	7.63e-05	0.00086	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—AQP3—urinary bladder cancer	7.58e-05	0.000854	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—IL2—urinary bladder cancer	7.56e-05	0.000853	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTT1—urinary bladder cancer	7.51e-05	0.000847	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	7.5e-05	0.000846	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—IGF1—urinary bladder cancer	7.42e-05	0.000836	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	7.4e-05	0.000834	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCNE1—urinary bladder cancer	7.36e-05	0.000829	CbGpPWpGaD
Vinorelbine—CYP2D6—Biological oxidations—GSTM1—urinary bladder cancer	7.32e-05	0.000825	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TYMS—urinary bladder cancer	7.23e-05	0.000815	CbGpPWpGaD
Vinorelbine—CYP2D6—Metapathway biotransformation—GSTM1—urinary bladder cancer	7.22e-05	0.000814	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—IGF1—urinary bladder cancer	7.18e-05	0.000809	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—EP300—urinary bladder cancer	7.04e-05	0.000794	CbGpPWpGaD
Vinorelbine—TUBB4A—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	7.03e-05	0.000792	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—IGF1—urinary bladder cancer	7.02e-05	0.000792	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—RB1—urinary bladder cancer	6.98e-05	0.000787	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN2A—urinary bladder cancer	6.86e-05	0.000773	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CCND1—urinary bladder cancer	6.84e-05	0.000771	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN2A—urinary bladder cancer	6.71e-05	0.000756	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—CDKN1A—urinary bladder cancer	6.62e-05	0.000746	CbGpPWpGaD
Vinorelbine—TUBB4B—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	6.43e-05	0.000724	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—FAS—urinary bladder cancer	6.4e-05	0.000722	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	6.34e-05	0.000714	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—IGF1—urinary bladder cancer	6.31e-05	0.000711	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—EP300—urinary bladder cancer	6.3e-05	0.00071	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TRPV1—urinary bladder cancer	6.18e-05	0.000696	CbGpPWpGaD
Vinorelbine—TUBB6—Metabolism of proteins—CXCL8—urinary bladder cancer	6.18e-05	0.000696	CbGpPWpGaD
Vinorelbine—TUBB2B—Metabolism of proteins—CXCL8—urinary bladder cancer	6.18e-05	0.000696	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle, Mitotic—MYC—urinary bladder cancer	6.14e-05	0.000692	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN2A—urinary bladder cancer	6.14e-05	0.000692	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	6.13e-05	0.000691	CbGpPWpGaD
Vinorelbine—TUBB3—Metabolism of proteins—CXCL8—urinary bladder cancer	5.96e-05	0.000672	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—EP300—urinary bladder cancer	5.83e-05	0.000658	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CCND1—urinary bladder cancer	5.8e-05	0.000653	CbGpPWpGaD
Vinorelbine—TUBB2A—Metabolism of proteins—CXCL8—urinary bladder cancer	5.78e-05	0.000651	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—IGF1—urinary bladder cancer	5.77e-05	0.00065	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CCND1—urinary bladder cancer	5.67e-05	0.000639	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ATM—urinary bladder cancer	5.66e-05	0.000638	CbGpPWpGaD
Vinorelbine—TUBB1—Metabolism of proteins—CXCL8—urinary bladder cancer	5.65e-05	0.000637	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDK4—urinary bladder cancer	5.64e-05	0.000635	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ESR1—urinary bladder cancer	5.61e-05	0.000632	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—CDKN1A—urinary bladder cancer	5.61e-05	0.000632	CbGpPWpGaD
Vinorelbine—ABCB1—Allograft Rejection—TNF—urinary bladder cancer	5.51e-05	0.000621	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—MYC—urinary bladder cancer	5.49e-05	0.000618	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—CDKN1A—urinary bladder cancer	5.48e-05	0.000618	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—EP300—urinary bladder cancer	5.34e-05	0.000601	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—EP300—urinary bladder cancer	5.22e-05	0.000588	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTP1—urinary bladder cancer	5.21e-05	0.000587	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CCND1—urinary bladder cancer	5.18e-05	0.000584	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTZ1—urinary bladder cancer	5.18e-05	0.000584	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTP1—urinary bladder cancer	5.14e-05	0.000579	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle, Mitotic—MYC—urinary bladder cancer	5.08e-05	0.000573	CbGpPWpGaD
Vinorelbine—TUBB4A—Metabolism of proteins—CXCL8—urinary bladder cancer	5.07e-05	0.000572	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—CDKN1A—urinary bladder cancer	5.01e-05	0.000565	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CREBBP—urinary bladder cancer	4.92e-05	0.000554	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTO2—urinary bladder cancer	4.91e-05	0.000553	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NAT1—urinary bladder cancer	4.91e-05	0.000553	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTZ1—urinary bladder cancer	4.88e-05	0.00055	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—IGF1—urinary bladder cancer	4.86e-05	0.000547	CbGpPWpGaD
Vinorelbine—CYP3A4—Biological oxidations—GSTM1—urinary bladder cancer	4.79e-05	0.000539	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—EP300—urinary bladder cancer	4.77e-05	0.000538	CbGpPWpGaD
Vinorelbine—CYP3A4—Metapathway biotransformation—GSTM1—urinary bladder cancer	4.72e-05	0.000532	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle, Mitotic—MYC—urinary bladder cancer	4.65e-05	0.000524	CbGpPWpGaD
Vinorelbine—TUBB4B—Metabolism of proteins—CXCL8—urinary bladder cancer	4.64e-05	0.000523	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTO2—urinary bladder cancer	4.63e-05	0.000521	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NAT1—urinary bladder cancer	4.63e-05	0.000521	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—MYC—urinary bladder cancer	4.55e-05	0.000512	CbGpPWpGaD
Vinorelbine—TUBB—Cell Cycle—TP53—urinary bladder cancer	4.51e-05	0.000508	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—UGT2B7—urinary bladder cancer	4.49e-05	0.000506	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—UGT2B7—urinary bladder cancer	4.23e-05	0.000477	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—TFRC—urinary bladder cancer	4.17e-05	0.00047	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—MYC—urinary bladder cancer	4.16e-05	0.000469	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—ERBB2—urinary bladder cancer	4.12e-05	0.000464	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CYP4B1—urinary bladder cancer	4.04e-05	0.000456	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTGS2—urinary bladder cancer	4.03e-05	0.000454	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—SLC19A1—urinary bladder cancer	3.82e-05	0.00043	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CYP4B1—urinary bladder cancer	3.81e-05	0.000429	CbGpPWpGaD
Vinorelbine—TUBB4A—Cell Cycle—TP53—urinary bladder cancer	3.73e-05	0.000421	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PRSS3—urinary bladder cancer	3.72e-05	0.000419	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CCND1—urinary bladder cancer	3.64e-05	0.00041	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—SLC19A1—urinary bladder cancer	3.6e-05	0.000406	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—CDKN1A—urinary bladder cancer	3.52e-05	0.000397	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—PTEN—urinary bladder cancer	3.51e-05	0.000396	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PRSS3—urinary bladder cancer	3.51e-05	0.000395	CbGpPWpGaD
Vinorelbine—TUBB4B—Cell Cycle—TP53—urinary bladder cancer	3.41e-05	0.000385	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EP300—urinary bladder cancer	3.35e-05	0.000378	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—SRC—urinary bladder cancer	3.26e-05	0.000367	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTZ1—urinary bladder cancer	3.19e-05	0.00036	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTO2—urinary bladder cancer	3.02e-05	0.000341	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAT1—urinary bladder cancer	3.02e-05	0.000341	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMP—urinary bladder cancer	2.97e-05	0.000335	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—MYC—urinary bladder cancer	2.92e-05	0.000329	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—EGFR—urinary bladder cancer	2.85e-05	0.000322	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMP—urinary bladder cancer	2.8e-05	0.000316	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—UGT2B7—urinary bladder cancer	2.77e-05	0.000312	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TNF—urinary bladder cancer	2.72e-05	0.000306	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—KRAS—urinary bladder cancer	2.7e-05	0.000304	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NAT2—urinary bladder cancer	2.69e-05	0.000303	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NAT2—urinary bladder cancer	2.53e-05	0.000286	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CYP4B1—urinary bladder cancer	2.49e-05	0.000281	CbGpPWpGaD
Vinorelbine—ABCB1—Integrated Pancreatic Cancer Pathway—TP53—urinary bladder cancer	2.4e-05	0.00027	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—SLC19A1—urinary bladder cancer	2.35e-05	0.000265	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—RRM2—urinary bladder cancer	2.32e-05	0.000262	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PRSS3—urinary bladder cancer	2.29e-05	0.000258	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—RRM2—urinary bladder cancer	2.19e-05	0.000247	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—HPGDS—urinary bladder cancer	2.15e-05	0.000242	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ENO2—urinary bladder cancer	2.15e-05	0.000242	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTT1—urinary bladder cancer	2.09e-05	0.000235	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—HPGDS—urinary bladder cancer	2.03e-05	0.000228	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ENO2—urinary bladder cancer	2.03e-05	0.000228	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTT1—urinary bladder cancer	1.97e-05	0.000222	CbGpPWpGaD
Vinorelbine—ABCB1—Transmembrane transport of small molecules—CREBBP—urinary bladder cancer	1.95e-05	0.00022	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMP—urinary bladder cancer	1.83e-05	0.000207	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NQO1—urinary bladder cancer	1.73e-05	0.000195	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NAT2—urinary bladder cancer	1.66e-05	0.000187	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NQO1—urinary bladder cancer	1.63e-05	0.000184	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTP1—urinary bladder cancer	1.45e-05	0.000163	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—RRM2—urinary bladder cancer	1.43e-05	0.000161	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTP1—urinary bladder cancer	1.36e-05	0.000154	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—TYMS—urinary bladder cancer	1.34e-05	0.000151	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—NCOR1—urinary bladder cancer	1.33e-05	0.00015	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GSTM1—urinary bladder cancer	1.33e-05	0.00015	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—HPGDS—urinary bladder cancer	1.32e-05	0.000149	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ENO2—urinary bladder cancer	1.32e-05	0.000149	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTT1—urinary bladder cancer	1.29e-05	0.000145	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—GPX1—urinary bladder cancer	1.27e-05	0.000143	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—TYMS—urinary bladder cancer	1.27e-05	0.000143	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—NCOR1—urinary bladder cancer	1.25e-05	0.000141	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GSTM1—urinary bladder cancer	1.25e-05	0.000141	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—ERCC2—urinary bladder cancer	1.25e-05	0.000141	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—GPX1—urinary bladder cancer	1.2e-05	0.000135	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—ERCC2—urinary bladder cancer	1.18e-05	0.000133	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—MTHFR—urinary bladder cancer	1.17e-05	0.000132	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—MTHFR—urinary bladder cancer	1.11e-05	0.000125	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NQO1—urinary bladder cancer	1.07e-05	0.00012	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PPARG—urinary bladder cancer	9.52e-06	0.000107	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—CREBBP—urinary bladder cancer	9.15e-06	0.000103	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PPARG—urinary bladder cancer	8.97e-06	0.000101	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTP1—urinary bladder cancer	8.91e-06	0.0001	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—CREBBP—urinary bladder cancer	8.62e-06	9.71e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—TYMS—urinary bladder cancer	8.28e-06	9.33e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—NCOR1—urinary bladder cancer	8.19e-06	9.23e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GSTM1—urinary bladder cancer	8.19e-06	9.23e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—GPX1—urinary bladder cancer	7.84e-06	8.83e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—ERCC2—urinary bladder cancer	7.7e-06	8.67e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTGS2—urinary bladder cancer	7.49e-06	8.44e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—MTHFR—urinary bladder cancer	7.23e-06	8.15e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTGS2—urinary bladder cancer	7.06e-06	7.95e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—PTEN—urinary bladder cancer	6.53e-06	7.36e-05	CbGpPWpGaD
Vinorelbine—ABCB1—Metabolism—EP300—urinary bladder cancer	6.23e-06	7.02e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—PTEN—urinary bladder cancer	6.16e-06	6.94e-05	CbGpPWpGaD
Vinorelbine—CYP2D6—Metabolism—EP300—urinary bladder cancer	5.87e-06	6.62e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PPARG—urinary bladder cancer	5.87e-06	6.61e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—CREBBP—urinary bladder cancer	5.64e-06	6.35e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTGS2—urinary bladder cancer	4.61e-06	5.2e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—PTEN—urinary bladder cancer	4.02e-06	4.54e-05	CbGpPWpGaD
Vinorelbine—CYP3A4—Metabolism—EP300—urinary bladder cancer	3.84e-06	4.33e-05	CbGpPWpGaD
